NEW YORK (GenomeWeb News) – Life sciences company Warnex and microRNA-based molecular diagnostics developer Rosetta Genomics announced today that Warnex Medical Laboratories has signed an exclusive agreement to distribute three of Rosetta's currently available diagnostic tests in Canada.

Under the agreement, Warnex will market the miRview mets test, the miRview squamous test, and the miRview meso test, and it will send Canadian samples to a CLIA-certified lab in Philadelphia for analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.